List of Tables
Table 1. Low Molecular Weight Heparin Market Trends
Table 2. Low Molecular Weight Heparin Market Drivers & Opportunity
Table 3. Low Molecular Weight Heparin Market Challenges
Table 4. Low Molecular Weight Heparin Market Restraints
Table 5. Global Low Molecular Weight Heparin Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Low Molecular Weight Heparin Revenue Market Share by Company (2020-2025)
Table 7. Global Low Molecular Weight Heparin Sales Volume by Company (2020-2025) & (MT)
Table 8. Global Low Molecular Weight Heparin Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Low Molecular Weight Heparin Price by Company (2020-2025) & (USD/MT)
Table 10. Key Manufacturers Low Molecular Weight Heparin Manufacturing Base and Headquarters
Table 11. Key Manufacturers Low Molecular Weight Heparin Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Low Molecular Weight Heparin
Table 13. Global Low Molecular Weight Heparin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Low Molecular Weight Heparin as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Low Molecular Weight Heparin Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Low Molecular Weight Heparin Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Low Molecular Weight Heparin Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Low Molecular Weight Heparin Sales Market Share in Value by Type (2020-2025)
Table 20. Global Low Molecular Weight Heparin Sales Market Share in Value by Type (2026-2031)
Table 21. Global Low Molecular Weight Heparin Sales Volume by Type: 2020 VS 2024 VS 2031 (MT)
Table 22. Global Low Molecular Weight Heparin Sales Volume by Type (2020-2025) & (MT)
Table 23. Global Low Molecular Weight Heparin Sales Volume by Type (2026-2031) & (MT)
Table 24. Global Low Molecular Weight Heparin Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Low Molecular Weight Heparin Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Low Molecular Weight Heparin Price by Type (2020-2025) & (USD/MT)
Table 27. Global Low Molecular Weight Heparin Price by Type (2026-2031) & (USD/MT)
Table 28. Global Low Molecular Weight Heparin Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Low Molecular Weight Heparin Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Low Molecular Weight Heparin Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Low Molecular Weight Heparin Sales Market Share in Value by Application (2020-2025)
Table 32. Global Low Molecular Weight Heparin Sales Market Share in Value by Application (2026-2031)
Table 33. Global Low Molecular Weight Heparin Sales Volume by Application: 2020 VS 2024 VS 2031 (MT)
Table 34. Global Low Molecular Weight Heparin Sales Volume by Application (2020-2025) & (MT)
Table 35. Global Low Molecular Weight Heparin Sales Volume by Application (2026-2031) & (MT)
Table 36. Global Low Molecular Weight Heparin Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Low Molecular Weight Heparin Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Low Molecular Weight Heparin Price by Application (2020-2025) & (USD/MT)
Table 39. Global Low Molecular Weight Heparin Price by Application (2026-2031) & (USD/MT)
Table 40. Global Low Molecular Weight Heparin Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Low Molecular Weight Heparin Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Low Molecular Weight Heparin Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Low Molecular Weight Heparin Sales Value by Region (2020-2025) & (%)
Table 44. Global Low Molecular Weight Heparin Sales Value by Region (2026-2031) & (%)
Table 45. Global Low Molecular Weight Heparin Sales Volume by Region (MT): 2020 VS 2024 VS 2031
Table 46. Global Low Molecular Weight Heparin Sales Volume by Region (2020-2025) & (MT)
Table 47. Global Low Molecular Weight Heparin Sales Volume by Region (2026-2031) & (MT)
Table 48. Global Low Molecular Weight Heparin Sales Volume by Region (2020-2025) & (%)
Table 49. Global Low Molecular Weight Heparin Sales Volume by Region (2026-2031) & (%)
Table 50. Global Low Molecular Weight Heparin Average Price by Region (2020-2025) & (USD/MT)
Table 51. Global Low Molecular Weight Heparin Average Price by Region (2026-2031) & (USD/MT)
Table 52. Key Countries/Regions Low Molecular Weight Heparin Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Low Molecular Weight Heparin Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Low Molecular Weight Heparin Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Low Molecular Weight Heparin Sales Volume, (2020-2025) & (MT)
Table 56. Key Countries/Regions Low Molecular Weight Heparin Sales Volume, (2026-2031) & (MT)
Table 57. Aspen Company Information
Table 58. Aspen Introduction and Business Overview
Table 59. Aspen Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. Aspen Low Molecular Weight Heparin Product Offerings
Table 61. Aspen Recent Development
Table 62. Sanofi-aventis Company Information
Table 63. Sanofi-aventis Introduction and Business Overview
Table 64. Sanofi-aventis Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 65. Sanofi-aventis Low Molecular Weight Heparin Product Offerings
Table 66. Sanofi-aventis Recent Development
Table 67. Pfizer Company Information
Table 68. Pfizer Introduction and Business Overview
Table 69. Pfizer Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 70. Pfizer Low Molecular Weight Heparin Product Offerings
Table 71. Pfizer Recent Development
Table 72. Opocrin Company Information
Table 73. Opocrin Introduction and Business Overview
Table 74. Opocrin Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Opocrin Low Molecular Weight Heparin Product Offerings
Table 76. Opocrin Recent Development
Table 77. CSBIO Company Information
Table 78. CSBIO Introduction and Business Overview
Table 79. CSBIO Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. CSBIO Low Molecular Weight Heparin Product Offerings
Table 81. CSBIO Recent Development
Table 82. Dongying Tiandong Pharmaceutical Company Information
Table 83. Dongying Tiandong Pharmaceutical Introduction and Business Overview
Table 84. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Product Offerings
Table 86. Dongying Tiandong Pharmaceutical Recent Development
Table 87. Changzhou Qianhong Bio-pharma Company Information
Table 88. Changzhou Qianhong Bio-pharma Introduction and Business Overview
Table 89. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Product Offerings
Table 91. Changzhou Qianhong Bio-pharma Recent Development
Table 92. Techdow Company Information
Table 93. Techdow Introduction and Business Overview
Table 94. Techdow Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 95. Techdow Low Molecular Weight Heparin Product Offerings
Table 96. Techdow Recent Development
Table 97. Yantai Dongcheng Pharmaceutical Group Company Information
Table 98. Yantai Dongcheng Pharmaceutical Group Introduction and Business Overview
Table 99. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 100. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Product Offerings
Table 101. Yantai Dongcheng Pharmaceutical Group Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Low Molecular Weight Heparin Downstream Customers
Table 105. Low Molecular Weight Heparin Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Low Molecular Weight Heparin Product Picture
Figure 2. Global Low Molecular Weight Heparin Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Low Molecular Weight Heparin Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Low Molecular Weight Heparin Sales Volume (2020-2031) & (MT)
Figure 5. Global Low Molecular Weight Heparin Sales Price (2020-2031) & (USD/MT)
Figure 6. Low Molecular Weight Heparin Report Years Considered
Figure 7. Global Low Molecular Weight Heparin Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Low Molecular Weight Heparin Players Sales Volume Ranking (2024) & (MT)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Low Molecular Weight Heparin Revenue in 2024
Figure 10. Low Molecular Weight Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Enoxaparin Picture
Figure 12. Dalteparin Picture
Figure 13. Tinzaparin Picture
Figure 14. Fraxiparine Picture
Figure 15. Global Low Molecular Weight Heparin Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 16. Global Low Molecular Weight Heparin Sales Value Market Share by Type, 2024 & 2031
Figure 17. Global Low Molecular Weight Heparin Sales Volume by Type (2020 VS 2024 VS 2031) & (MT)
Figure 18. Global Low Molecular Weight Heparin Sales Volume Market Share by Type, 2024 & 2031
Figure 19. Global Low Molecular Weight Heparin Price by Type (2020-2031) & (USD/MT)
Figure 20. Product Picture of Treatment of Venous Thromboembolism
Figure 21. Product Picture of Complications of Pregnancy
Figure 22. Product Picture of Cardioversion of Atrial Fibrillation/Flutter
Figure 23. Product Picture of Others
Figure 24. Global Low Molecular Weight Heparin Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 25. Global Low Molecular Weight Heparin Sales Value Market Share by Application, 2024 & 2031
Figure 26. Global Low Molecular Weight Heparin Sales Volume by Application (2020 VS 2024 VS 2031) & (MT)
Figure 27. Global Low Molecular Weight Heparin Sales Volume Market Share by Application, 2024 & 2031
Figure 28. Global Low Molecular Weight Heparin Price by Application (2020-2031) & (USD/MT)
Figure 29. North America Low Molecular Weight Heparin Sales Value (2020-2031) & (US$ Million)
Figure 30. North America Low Molecular Weight Heparin Sales Value by Country (%), 2024 VS 2031
Figure 31. Europe Low Molecular Weight Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 32. Europe Low Molecular Weight Heparin Sales Value by Country (%), 2024 VS 2031
Figure 33. Asia Pacific Low Molecular Weight Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Low Molecular Weight Heparin Sales Value by Region (%), 2024 VS 2031
Figure 35. South America Low Molecular Weight Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 36. South America Low Molecular Weight Heparin Sales Value by Country (%), 2024 VS 2031
Figure 37. Middle East & Africa Low Molecular Weight Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 38. Middle East & Africa Low Molecular Weight Heparin Sales Value by Country (%), 2024 VS 2031
Figure 39. Key Countries/Regions Low Molecular Weight Heparin Sales Value (%), (2020-2031)
Figure 40. Key Countries/Regions Low Molecular Weight Heparin Sales Volume (%), (2020-2031)
Figure 41. United States Low Molecular Weight Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 42. United States Low Molecular Weight Heparin Sales Value by Type (%), 2024 VS 2031
Figure 43. United States Low Molecular Weight Heparin Sales Value by Application (%), 2024 VS 2031
Figure 44. Europe Low Molecular Weight Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 45. Europe Low Molecular Weight Heparin Sales Value by Type (%), 2024 VS 2031
Figure 46. Europe Low Molecular Weight Heparin Sales Value by Application (%), 2024 VS 2031
Figure 47. China Low Molecular Weight Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 48. China Low Molecular Weight Heparin Sales Value by Type (%), 2024 VS 2031
Figure 49. China Low Molecular Weight Heparin Sales Value by Application (%), 2024 VS 2031
Figure 50. Japan Low Molecular Weight Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 51. Japan Low Molecular Weight Heparin Sales Value by Type (%), 2024 VS 2031
Figure 52. Japan Low Molecular Weight Heparin Sales Value by Application (%), 2024 VS 2031
Figure 53. South Korea Low Molecular Weight Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 54. South Korea Low Molecular Weight Heparin Sales Value by Type (%), 2024 VS 2031
Figure 55. South Korea Low Molecular Weight Heparin Sales Value by Application (%), 2024 VS 2031
Figure 56. Southeast Asia Low Molecular Weight Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 57. Southeast Asia Low Molecular Weight Heparin Sales Value by Type (%), 2024 VS 2031
Figure 58. Southeast Asia Low Molecular Weight Heparin Sales Value by Application (%), 2024 VS 2031
Figure 59. India Low Molecular Weight Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 60. India Low Molecular Weight Heparin Sales Value by Type (%), 2024 VS 2031
Figure 61. India Low Molecular Weight Heparin Sales Value by Application (%), 2024 VS 2031
Figure 62. Low Molecular Weight Heparin Industrial Chain
Figure 63. Low Molecular Weight Heparin Manufacturing Cost Structure
Figure 64. Channels of Distribution (Direct Sales, and Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
